AIM2 and hepatocellular carcinoma: In the context of hepatocellular carcinoma (HCC), AIM2 has been found to suppress HCC cell proliferation, colony formation, and invasion by inducing pyroptosis through inflammasome formation, consequently inhibiting the mTOR-S6K1 pathway and hindering tumor progression22.